Notícia

World Today News

Breakthrough Zika Vaccine Developed by Brazilian Researchers Ready for Clinical Testing (106 notícias)

Publicado em 05 de abril de 2024

Gizmodo Brasil Guia Viver Bem Jornal Alerta Infofix Folha de Dourados online O Sul online Mais Top News Portal Nine Rádio Pampa FM 97,5 Tudo ao Vivo Rondonotícias TV Pampa ABC do ABC SnifBrasil La Crónica de Hoy (México) online Fora de Eixo Enfarma (México) Xeu (México) La Otra Versión (Venezuela) Noticias NCC - Noticiero Científico y Cultural Iberoamericano (México) Primicias 24 Portal do Generoso Expresso das Ilhas (Cabo Verde) HealthNews (Portugal) Diário de Notícias Madeira (Portugal) online Meu Site Brasil Papo Saúde Tech Blog (SP) O Antagonista O Progresso (Dourados, MS) online BN - Bahia Notícias Em Notícia Crónica Puebla (México) Voz Global (República Dominica) Jornal da USP online Noticias 22 (República Dominicana) Noticias Telemicro (República Dominicana) NewsLab online Revista Circuito (Cotia, SP) online O Defensor online Feed Notícias Portal Gilberto Silva EnEspañol24 (Espanha) Repórter PB Jornal Floripa MS Destaque Rede BCN Tribuna do Agreste EhTrend! O Sul Blog O Cubo Medicina S/A Vegazeta Radar Amazônico Jornal Integração Net Farma - Portal dos Profissionais do Setor Farmacêutico (Portugal) Saúde em Tela Batatais 24h ANADEM - Sociedade Brasileira de Direito Médico e Bioética Naturorama (França) Confap - Conselho Nacional das Fundações Estaduais de Amparo à Pesquisa Saense AC24Horas Itamaraju Notícias Market Insider CREMERJ-RJ Amazônia Press Blog do Danilo Evaristo Maceió Brasil Revista Oeste online São Bento em Foco AM Post Portal Nosso Goiás O2 Labs Agência 24h

A vaccine against Zika developed by Brazilian researchers was effective against the virus in tests carried out with laboratory mice and is ready to be subjected to clinical tests, scientific sources reported this Friday.

The formula was highly effective in tests with mice; was able to induce the organism to generate an immune response against the pathogen and protected the animals from infection, according to the Research Support Foundation in the State of Sao Paulo (FAPESP), which financed part of the project.

The good results of this immunizer in preclinical tests were highlighted in the latest edition of the scientific journal Frontiers in Immunology.

The vaccine was developed by scientists from the University of Sao Paulo and the Oswaldo Cruz Foundation (Fiocruz), the largest health research center in Brazil, using promising nucleic acid (DNA) manipulation technologies.

«When we talk about vaccines, we usually think about the inoculation of the attenuated or inactivated virus. But DNA vaccines are a more advanced technology that evolved in the last 30 years and became a powerful therapeutic platform,” said Maria Sato, USP researcher and project coordinator, quoted in a FAPESP bulletin.

The specialist explained that DNA vaccines are cheaper and potentially more effective than those made from the inactivated virus.

He added that those responsible for the project developed four different DNA vaccine formulas that encode part of the protein complex that externally covers the Zika virus.

In this way, once inoculated, these vaccines are capable of inducing the body to produce antibodies to neutralize the pathogen and provoke an immune response to Zika.

In tests with mice, the immunizer achieved a high immune system response in adult animals, through the generation of high levels of neutralizing antibodies.

“The results showed that the vaccine is effective and that its development must be continued with new studies,” said Franciane Teixeira, another of those responsible for the project.

Despite the recent outbreaks of Zika in some American countries, there is still no vaccine to protect the body against the virus transmitted by the Aedes aegypti mosquito.

Text: Efe